This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Maxwell Biotech Group Ltd.. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2022
Title: Lisa Lynn Caralli: Innovator in Oncology and Pharmaceuticals
Introduction
Lisa Lynn Caralli is a prominent inventor based in Del Mar, California. She has made significant contributions to the field of medicine and pharmaceuticals, particularly in oncology. With a total of 2 patents, her work focuses on developing innovative treatments for bone lesions caused by malignant neoplasms.
Latest Patents
Caralli's latest patents include a stable dosage form of etidronate-cytarabine conjugate and a pharmaceutical preparation for treating bone lesions caused by malignant neoplasms. The first patent relates to a novel dosage form that ensures the hydrolytic and physical stability of an antitumor preparation. This stable dosage form is a lyophilizate comprising an etidronate-cytarabine conjugate or a pharmaceutically acceptable salt, along with a stabilizer. The stabilizer is a divalent metal salt, which is crucial for maintaining the stability of the conjugate during long-term storage and clinical use. The second patent proposes a medicinal drug that represents a lyophilisate for solution for parenteral administration, aimed at treating bone lesions caused by malignant tumors. This drug allows for intravenous administration, significantly reducing the metabolic activity of bone lesions.
Career Highlights
Lisa Lynn Caralli is associated with Maxwell Biotech Group Ltd., where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in advancing treatment options for patients suffering from severe conditions related to oncology.
Collaborations
Some of her notable coworkers include Ekaterina Alekseevna Ivanova and Alexander Karpeisky, who contribute to her research and development efforts.
Conclusion
Lisa Lynn Caralli's contributions to the field of pharmaceuticals and oncology highlight her dedication to improving patient outcomes through innovative treatments. Her patents reflect a commitment to advancing medical science and providing effective solutions for complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile